263 related articles for article (PubMed ID: 32448839)
1. Development of Severe Heart Failure in a Patient with Squamous Non-small-cell Lung Cancer During Nivolumab Treatment.
Samejima Y; Iuchi A; Kanai T; Noda Y; Nasu S; Tanaka A; Morishita N; Suzuki H; Okamoto N; Harada H; Ezumi A; Ueda K; Kawahara K; Hirashima T
Intern Med; 2020 Aug; 59(16):2003-2008. PubMed ID: 32448839
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy.
Canale ML; Camerini A; Casolo G; Lilli A; Bisceglia I; Parrini I; Lestuzzi C; Del Meglio J; Puccetti C; Camerini L; Amoroso D; Maurea N
Adv Ther; 2020 Jul; 37(7):3178-3184. PubMed ID: 32436027
[TBL] [Abstract][Full Text] [Related]
3. Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab.
Sato K; Akamatsu H; Murakami E; Sasaki S; Kanai K; Hayata A; Tokudome N; Akamatsu K; Koh Y; Ueda H; Nakanishi M; Yamamoto N
Lung Cancer; 2018 Jan; 115():71-74. PubMed ID: 29290265
[TBL] [Abstract][Full Text] [Related]
4. Follicular lymphoma generating in a patient with non-small cell lung cancer following nivolumab discontinuation.
Sengul Samanci N; Yılmaz U; Bedir S; Ozgur Yurttas N; Oruc K; Durak Sahin Z; Celik E; Toplutas KN; Akı H; Eskazan AE; Demirelli FH
J Oncol Pharm Pract; 2020 Dec; 26(8):2042-2046. PubMed ID: 32299317
[TBL] [Abstract][Full Text] [Related]
5. Nivolumab-associated Stevens-Johnson syndrome in a patient with lung cancer.
Gracia-Cazaña T; Padgett E; Calderero V; Oncins R
Dermatol Online J; 2021 Mar; 27(3):. PubMed ID: 33865285
[TBL] [Abstract][Full Text] [Related]
6. Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.
Saka H; Nishio M; Hida T; Nakagawa K; Sakai H; Nogami N; Atagi S; Takahashi T; Horinouchi H; Takenoyama M; Katakami N; Tanaka H; Takeda K; Satouchi M; Isobe H; Maemondo M; Goto K; Hirashima T; Minato K; Yada N; Tamura T
Jpn J Clin Oncol; 2021 Jan; 51(1):106-113. PubMed ID: 33020837
[TBL] [Abstract][Full Text] [Related]
7. [Dermatomyositis with squamous cell carcinoma of the lungs secondary to nivolumab treatment: a case report].
Miyashita K; Kajikawa H; Utsunomiya T; Hosaka M; Naito Y; Tomimoto H
Rinsho Shinkeigaku; 2020 Nov; 60(11):768-772. PubMed ID: 33115992
[TBL] [Abstract][Full Text] [Related]
8. IMMUNE RETINOPATHY ASSOCIATED WITH NIVOLUMAB ADMINISTRATION FOR METASTATIC NON-SMALL CELL LUNG CANCER.
Reddy M; Chen JJ; Kalevar A; Terribilini R; Agarwal A
Retin Cases Brief Rep; 2020; 14(2):120-126. PubMed ID: 29176534
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Early Death in Japanese Patients With Advanced Non-small-cell Lung Cancer Treated With Nivolumab.
Inoue T; Tamiya M; Tamiya A; Nakahama K; Taniguchi Y; Shiroyama T; Isa SI; Nishino K; Kumagai T; Kunimasa K; Kimura M; Suzuki H; Hirashima T; Atagi S; Imamura F
Clin Lung Cancer; 2018 Mar; 19(2):e171-e176. PubMed ID: 29133121
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of Advanced or Postoperative Recurrent Non-small Lung Cancer Cases Treated with Nivolumab].
Ichiki Y; Iwanami T; Kakizoe K; Hamatsu T; Suehiro T; Yoneda K; Tanaka F; Sugimachi K
J UOEH; 2017; 39(4):291-297. PubMed ID: 29249742
[TBL] [Abstract][Full Text] [Related]
11. [Third degree atrio-ventricular blockade during a myocarditis occurring under anti-PD1 : Case report and literature review].
Prevel R; Colin G; Calès V; Renault PA; Mazieres J
Rev Med Interne; 2020 Apr; 41(4):284-288. PubMed ID: 31983550
[TBL] [Abstract][Full Text] [Related]
12. Severe pulmonary infections complicating nivolumab treatment for lung cancer: a report of two cases.
Inthasot V; Bruyneel M; Muylle I; Ninane V
Acta Clin Belg; 2020 Aug; 75(4):308-310. PubMed ID: 31179880
[TBL] [Abstract][Full Text] [Related]
13. Nivolumab-induced fulminant type 1 diabetes with precipitous fall in C-peptide level.
Miyauchi M; Toyoda M; Zhang J; Hamada N; Yamawaki T; Tanaka J; Harada K; Kashizaki F; Fukagawa M
J Diabetes Investig; 2020 May; 11(3):748-749. PubMed ID: 31587459
[TBL] [Abstract][Full Text] [Related]
14. Nivolumab increases pulmonary artery pressure in patients treated for non-small cell lung cancer.
Fournel L; Boudou-Rouquette P; Prieto M; Hervochon R; Guinet C; Arrondeau J; Alexandre J; Damotte D; Wislez M; Batteux F; Icard P; Goldwasser F; Alifano M
Cancer Chemother Pharmacol; 2020 Oct; 86(4):497-505. PubMed ID: 32936316
[TBL] [Abstract][Full Text] [Related]
15. Emerging concerns of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy.
Fujita K; Kim YH; Kanai O; Yoshida H; Mio T; Hirai T
Respir Med; 2019 Jan; 146():66-70. PubMed ID: 30665520
[TBL] [Abstract][Full Text] [Related]
16. Real-world effectiveness of nivolumab in patients with non-small-cell lung cancer: a systematic review and meta-analysis.
Kim YJ; Oremus M; Chen HH; McFarlane T; Shah D; Horton S
Future Oncol; 2020 Sep; 16(27):2045-2058. PubMed ID: 32598192
[No Abstract] [Full Text] [Related]
17. [A Case Report of Checkpoint Inhibitor Pneumonitis Caused by PD-1
Antibody-Safety and Effectiveness of Pirfenidone].
Yu H; Li J; Yu L; Cheng X; Han X; Zhang X
Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):519-525. PubMed ID: 34134189
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression for Immune Checkpoint-related Toxicity Can Cause Pneumocystis Jirovecii Pneumonia (PJP) in Non-small-cell Lung Cancer (NSCLC): A Report of 2 Cases.
Schwarz M; Kocher F; Niedersuess-Beke D; Rudzki J; Hochmair M; Widmann G; Hilbe W; Pircher A
Clin Lung Cancer; 2019 May; 20(3):e247-e250. PubMed ID: 30635258
[No Abstract] [Full Text] [Related]
19. Toxic epidermal necrolysis occurring with immune checkpoint inhibitors.
Gopee NH; Gourley AM; Oliphant TJ; Hampton PJ
Dermatol Online J; 2020 Aug; 26(8):. PubMed ID: 32941713
[TBL] [Abstract][Full Text] [Related]
20. Immune Checkpoint Inhibitor Can Reduce HCV-RNA without Liver Damage.
Fukuda R; Sugawara S; Kondo Y
Intern Med; 2020 Sep; 59(18):2245-2248. PubMed ID: 32522918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
